Literature DB >> 17898021

Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB.

Joseph C K Leung1, Sydney C W Tang, Loretta Y Y Chan, Wai Long Chan, Kar Neng Lai.   

Abstract

BACKGROUND: Deposition of polymeric IgA1 (pIgA) in kidney mesangium is the hallmark of IgA nephropathy (IgAN). Current consensus is that a fraction of IgA1 molecules in the circulation of IgAN patients exhibit aberrant structures or properties that may lead to their deposition. Our previous findings suggest that the anionic property of IgA1 may play a role in mesangial IgA1 deposition in patients with IgAN. In the present study, the functional consequences of the binding of anionic polymeric IgA1 to human mesangial cells (HMCs) were investigated.
METHODS: Anionic polymeric IgA1 from IgAN patients and healthy subjects was isolated by sequential jacalin affinity chromatography, size exclusion chromatography using size exclusion and MonoQ ion exchange chromatography. HMCs were cultured with purified anionic polymeric IgA1 and the release of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) was examined by enzyme-linked immunosorbent assay. The signalling pathways involved in anionic pIgA-mediated HMC activation were examined by immunoblotting. Standard electrophoretic mobility shift assay (EMSA) was used to further examine whether the transcriptional factor NF-kappaB is associated in the signalling process. To define the mechanism of TNF-alpha and IL-6 production, HMCs were cultured with anionic pIgA in the presence or absence of p42/p44 mitogen-activated protein kinase (MAPK) inhibitor (PD98059), NF-kappaB inhibitor pyrrolidine dithiocarbamate (PDTC) or NF-kappaB blocking permeable peptides.
RESULTS: Compared with less anionic pIgA or monomeric IgA1 (mIgA), anionic pIgA from patient with IgAN significantly increased cell proliferation (P<0.05) when cultured with HMC. These anionic pIgA significantly increased the synthesis of TNF-alpha (P<0.05) and IL-6 (P<0.05) in a dose and time-dependent manner. Furthermore, the increased synthesis of IL-6 and TNF-alpha by anionic pIgA in HMC was significantly diminished (P<0.01) in the presence of NF-kappaB inhibitor pyrrolidine dithiocarbamate and NF-kappaB blocking permeable peptides SN50 (P<0.01). The increased synthesis of IL-6 by anionic pIgA in HMC was reduced by inhibitor to NF-kappaB or p42/p44 MAPK and was abolished by the simultaneous presence of inhibitors to p42/p44 MAPK and NF-kappaB. The up-regulation of TNF-alpha was partially suppressed by inhibitor to NF-kappaB but not PD98059.
CONCLUSION: Our results suggest that polymeric anionic IgA1 could activate HMC and increase the synthesis of TNF-alpha and IL-6. While both the p42/p44 MAPK and NF-kappaB pathways are essential in regulating the anionic pIgA-induced synthesis of IL-6, TNF-alpha synthesis mediated by anionic pIgA is partly dependent on NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898021     DOI: 10.1093/ndt/gfm581

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

Review 1.  Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Jiri Mestecky; Matthew B Renfrow
Journal:  Semin Immunopathol       Date:  2012-03-21       Impact factor: 9.623

2.  Hepatitis B virus X protein up-regulates tumor necrosis factor-α expression in cultured mesangial cells via ERKs and NF-κB pathways.

Authors:  Hong-Zhu Lu; Jian-Hua Zhou
Journal:  Asian Pac J Trop Biomed       Date:  2013-03

3.  Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell.

Authors:  Jing Xiao; Weijun Chen; Yijun Lu; Xiaoli Zhang; Chensheng Fu; Zhenwen Yan; Zhenxing Zhang; Zhibin Ye
Journal:  Inflamm Res       Date:  2015-06-14       Impact factor: 4.575

4.  Wedelolactone from Eclipta alba inhibits lipopolysaccharide-enhanced cell proliferation of human renal mesangial cells via NF-κB signaling pathway.

Authors:  Peicheng Shen; Xuejun Yang; Jian Jiang; Xianxian Wang; Tingyu Liang; Liqun He
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

5.  Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation.

Authors:  Utpal Sen; Srikanth Givvimani; Oluwasegun A Abe; Eleanor D Lederer; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-13       Impact factor: 4.249

6.  Corticosteroids Should Be Used To Treat Slowly Progressive IgA Nephropathy: PRO.

Authors:  Amanda M Cunningham; Heather N Reich
Journal:  Kidney360       Date:  2021-02-05

Review 7.  Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.

Authors:  Rosanna Coppo
Journal:  J Am Soc Nephrol       Date:  2016-09-26       Impact factor: 10.121

8.  Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.

Authors:  Zina Moldoveanu; Hitoshi Suzuki; Colin Reily; Kenji Satake; Lea Novak; Nuo Xu; Zhi-Qiang Huang; Barbora Knoppova; Atlas Khan; Stacy Hall; Hiroyuki Yanagawa; Rhubell Brown; Colleen J Winstead; Darrell B O'Quinn; Amy Weinmann; Ali G Gharavi; Krzysztof Kiryluk; Bruce A Julian; Casey T Weaver; Yusuke Suzuki; Jan Novak
Journal:  J Autoimmun       Date:  2021-01-25       Impact factor: 7.094

9.  Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.

Authors:  Hitoshi Suzuki; Milan Raska; Koshi Yamada; Zina Moldoveanu; Bruce A Julian; Robert J Wyatt; Yasuhiko Tomino; Ali G Gharavi; Jan Novak
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

Review 10.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.